EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Direct Comparison of Treatment Outcome Between the Botulinum Toxin and Calcitonin Gene-Related Peptide Monoclonal Antibody in Migraine Patients

Majed Mohammad Alabdali, Nazish Rafique iD, Deena A AlDossary, Rahaf S Alalloush, Haya A AlHemli, Mohammad Zeerak, Rabia Latif, Lubna Ibrahim Al-Asoom, Ahmed Abdulrahman AlSunni, Ayad Mohammed Salem, Mohammed Alshurem, Dana Aljaafari und 2 weitere

Journal of Clinical Medicine Research · 2024-11 · 16 (11) · 527-535

DOI: 10.14740/jocmr6054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine Research, 2024-11. Verfasst von Majed Mohammad Alabdali und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Botulinum neurotoxinCalcitonin gene-related peptide inhibitorsMigraine

Autor:innen und Institutionen

  • Department of Neurology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
  • Department of Physiology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
  • College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
  • Karlsruhe University of applied sciences, Karlsruhe, Germany.
  • Foundation University Medical College, FUIC, Islamabad.
  • College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.

ORCID-Profile: Nazish Rafique

Zitieren

APA

Mohammad Alabdali, M., Rafique, N., AlDossary, D. A., Alalloush, R. S., AlHemli, H. A., Zeerak, M., Latif, R., Ibrahim Al-Asoom, L., Abdulrahman AlSunni, A., Mohammed Salem, A., Alshurem, M., Aljaafari, D., Obaid, S., & Alabdulhadi, A. (2024). Direct Comparison of Treatment Outcome Between the Botulinum Toxin and Calcitonin Gene-Related Peptide Monoclonal Antibody in Migraine Patients. Journal of Clinical Medicine Research, 16(11), 527-535. https://doi.org/10.14740/jocmr6054

Vancouver

Mohammad Alabdali M, Rafique N, AlDossary DA, Alalloush RS, AlHemli HA, Zeerak M, et al. Direct Comparison of Treatment Outcome Between the Botulinum Toxin and Calcitonin Gene-Related Peptide Monoclonal Antibody in Migraine Patients. Journal of Clinical Medicine Research. 2024;16(11):527-535. doi:10.14740/jocmr6054

BibTeX
@article{MohammadAlabdali2024,
  author = {Mohammad Alabdali, Majed and Rafique, Nazish and AlDossary, Deena A and Alalloush, Rahaf S and AlHemli, Haya A and Zeerak, Mohammad and Latif, Rabia and Ibrahim Al-Asoom, Lubna and Abdulrahman AlSunni, Ahmed and Mohammed Salem, Ayad and Alshurem, Mohammed and Aljaafari, Dana and Obaid, Shumaila and Alabdulhadi, Aseel},
  title = {Direct Comparison of Treatment Outcome Between the Botulinum Toxin and Calcitonin Gene-Related Peptide Monoclonal Antibody in Migraine Patients},
  journal = {Journal of Clinical Medicine Research},
  year = {2024},
  volume = {16},
  number = {11},
  pages = {527--535},
  doi = {10.14740/jocmr6054}
}
Kostenlos starten →